RhumbLine Advisers’s Soleno Therapeutics SLNO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.95M | Buy |
59,046
+22,607
| +62% | +$1.89M | ﹤0.01% | 1422 |
|
|
2025
Q1 | $2.6M | Buy |
36,439
+2,044
| +6% | +$146K | ﹤0.01% | 1681 |
|
|
2024
Q4 | $1.55M | Buy |
34,395
+3,624
| +12% | +$163K | ﹤0.01% | 2019 |
|
|
2024
Q3 | $1.55M | Buy |
30,771
+1,627
| +6% | +$82.1K | ﹤0.01% | 2036 |
|
|
2024
Q2 | $1.19M | Buy |
+29,144
| New | +$1.19M | ﹤0.01% | 2150 |
|
|
2021
Q2 | – | Sell |
-2,840
| Closed | -$54K | – | 3095 |
|
|
2021
Q1 | $54K | Buy |
2,840
+102
| +4% | +$1.94K | ﹤0.01% | 2973 |
|
|
2020
Q4 | $79K | Buy |
2,738
+743
| +37% | +$21.4K | ﹤0.01% | 2991 |
|
|
2020
Q3 | $75K | Sell |
1,995
-171
| -8% | -$6.43K | ﹤0.01% | 2919 |
|
|
2020
Q2 | $72K | Buy |
+2,166
| New | +$72K | ﹤0.01% | 3002 |
|